NovoCure Ltd (NASDAQ: NVCR) is -8.14% lower on its value in year-to-date trading and has touched a low of $11.70 and a high of $34.13 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The NVCR stock was last observed hovering at around $27.45 in the last trading session, with the day’s loss setting it -0.07%.
Currently trading at $27.38, the stock is -9.74% and 12.02% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.83 million and changing -0.27% at the moment leaves the stock 42.00% off its SMA200. NVCR registered 95.33% gain for a year compared to 6-month gain of 52.25%. The firm has a 50-day simple moving average (SMA 50) of $24.2271 and a 200-day simple moving average (SMA200) of $19.2072.
The stock witnessed a -7.89% loss in the last 1 month and extending the period to 3 months gives it a 84.10%, and is -9.32% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.73% over the week and 5.61% over the month.
NovoCure Ltd (NVCR) has around 1453 employees, a market worth around $2.96B and $577.74M in sales. Profit margin for the company is -25.93%. Distance from 52-week low is 133.97% and -19.79% from its 52-week high. The company has generated returns on investments over the last 12 months (-31.27%).
with sales reaching $153.8M over the same period.The EPS is expected to grow by 32.90% this year, but quarterly earnings will post 17.35% year-over-year. Quarterly sales are estimated to grow 14.97% in year-over-year returns.
NovoCure Ltd (NVCR) Top Institutional Holders
322.0 institutions hold shares in NovoCure Ltd (NVCR), with institutional investors hold 96.80% of the company’s shares. The shares outstanding are 108.10M, and float is at 96.88M with Short Float at 5.57%. Institutions hold 87.48% of the Float.
The top institutional shareholder in the company is FMR LLC with over 16.14 million shares valued at $276.51 million. The investor’s holdings represent 15.0482% of the NVCR Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 12.13 million shares valued at $207.83 million to account for 11.3106 of the shares outstanding. The other top investors are CAPITAL INTERNATIONAL INVESTORS which holds 11.7 million shares representing 10.904% and valued at over $200.36 million, while VANGUARD GROUP INC holds 10.3736 of the shares totaling 11.13 million with a market value of $190.61 million.
NovoCure Ltd (NVCR) Insider Activity
#####
Still, SEC filings show that on Nov 02 ’24, Paravasthu Mukund (Chief Operating Officer) disposed off 44 shares at an average price of $16.69 for $734.0. The insider now directly holds 3,459 shares of NovoCure Ltd (NVCR).
